vs
Side-by-side financial comparison of Magyar Bancorp, Inc. (MGYR) and Prelude Therapeutics Inc (PRLD). Click either name above to swap in a different company.
Magyar Bancorp, Inc. is the larger business by last-quarter revenue ($8.9M vs $6.5M, roughly 1.4× Prelude Therapeutics Inc). Magyar Bancorp, Inc. runs the higher net margin — 35.4% vs -303.5%, a 338.9% gap on every dollar of revenue. On growth, Prelude Therapeutics Inc posted the faster year-over-year revenue change (116.7% vs 19.0%).
Magyar Bank is a bank based in New Brunswick, New Jersey with branches in Central Jersey.
MGYR vs PRLD — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.9M | $6.5M |
| Net Profit | $3.1M | $-19.7M |
| Gross Margin | — | — |
| Operating Margin | 48.3% | -314.1% |
| Net Margin | 35.4% | -303.5% |
| Revenue YoY | 19.0% | 116.7% |
| Net Profit YoY | 50.4% | 38.9% |
| EPS (diluted) | $0.50 | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.9M | — | ||
| Q3 25 | — | $6.5M | ||
| Q3 24 | — | $3.0M | ||
| Q2 24 | $7.2M | — | ||
| Q1 24 | $7.5M | — | ||
| Q4 23 | $7.9M | — |
| Q4 25 | $3.1M | — | ||
| Q3 25 | — | $-19.7M | ||
| Q3 24 | — | $-32.3M | ||
| Q2 24 | $1.7M | — | ||
| Q1 24 | $1.9M | — | ||
| Q4 23 | $1.7M | — |
| Q4 25 | 48.3% | — | ||
| Q3 25 | — | -314.1% | ||
| Q3 24 | — | -1145.9% | ||
| Q2 24 | 30.5% | — | ||
| Q1 24 | 32.1% | — | ||
| Q4 23 | 30.0% | — |
| Q4 25 | 35.4% | — | ||
| Q3 25 | — | -303.5% | ||
| Q3 24 | — | -1075.7% | ||
| Q2 24 | 23.5% | — | ||
| Q1 24 | 25.1% | — | ||
| Q4 23 | 21.0% | — |
| Q4 25 | $0.50 | — | ||
| Q3 25 | — | $-0.26 | ||
| Q3 24 | — | $-0.43 | ||
| Q2 24 | $0.27 | — | ||
| Q1 24 | $0.30 | — | ||
| Q4 23 | $0.26 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.1M | $55.0M |
| Total DebtLower is stronger | $49.1M | — |
| Stockholders' EquityBook value | $121.7M | $58.5M |
| Total Assets | $1.0B | $94.8M |
| Debt / EquityLower = less leverage | 0.40× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.1M | — | ||
| Q3 25 | — | $55.0M | ||
| Q3 24 | — | $153.6M | ||
| Q2 24 | $49.0M | — | ||
| Q1 24 | $50.0M | — | ||
| Q4 23 | $51.1M | — |
| Q4 25 | $49.1M | — | ||
| Q3 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | $121.7M | — | ||
| Q3 25 | — | $58.5M | ||
| Q3 24 | — | $156.4M | ||
| Q2 24 | $109.0M | — | ||
| Q1 24 | $107.6M | — | ||
| Q4 23 | $106.5M | — |
| Q4 25 | $1.0B | — | ||
| Q3 25 | — | $94.8M | ||
| Q3 24 | — | $197.2M | ||
| Q2 24 | $944.4M | — | ||
| Q1 24 | $928.6M | — | ||
| Q4 23 | $916.7M | — |
| Q4 25 | 0.40× | — | ||
| Q3 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.7M | $-19.1M |
| Free Cash FlowOCF − Capex | $3.7M | — |
| FCF MarginFCF / Revenue | 41.4% | — |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | 1.17× | — |
| TTM Free Cash FlowTrailing 4 quarters | $8.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.7M | — | ||
| Q3 25 | — | $-19.1M | ||
| Q3 24 | — | $-27.3M | ||
| Q2 24 | $1.7M | — | ||
| Q1 24 | $553.0K | — | ||
| Q4 23 | $3.2M | — |
| Q4 25 | $3.7M | — | ||
| Q3 25 | — | — | ||
| Q3 24 | — | $-27.4M | ||
| Q2 24 | $1.5M | — | ||
| Q1 24 | $428.0K | — | ||
| Q4 23 | $3.1M | — |
| Q4 25 | 41.4% | — | ||
| Q3 25 | — | — | ||
| Q3 24 | — | -912.0% | ||
| Q2 24 | 21.5% | — | ||
| Q1 24 | 5.7% | — | ||
| Q4 23 | 39.4% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | — | 0.0% | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 1.7% | — | ||
| Q4 23 | 1.6% | — |
| Q4 25 | 1.17× | — | ||
| Q3 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.00× | — | ||
| Q1 24 | 0.29× | — | ||
| Q4 23 | 1.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
